Analyst Scoreboard: 4 Ratings For Staar Surgical
Portfolio Pulse from Benzinga Insights
Staar Surgical (NASDAQ:STAA) has received mixed analyst ratings over the past three months, with a recent average price target of $43.75, down 7.41% from previous estimates. Analysts have adjusted their ratings and price targets, reflecting varied sentiments about the company's market performance. Despite positive revenue growth and strong financial metrics, the company's growth lags behind industry peers.
September 19, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Staar Surgical has received mixed analyst ratings, with a recent average price target of $43.75, indicating a 7.41% decline from prior estimates. Analysts have varied in their outlooks, with some lowering and others raising their price targets. Despite strong financial metrics, the company's growth is slower than its peers.
The mixed analyst ratings and the decline in the average price target suggest a neutral short-term impact on STAA's stock price. While the company's financial health is strong, the slower growth compared to peers may concern investors. The varied analyst opinions reflect uncertainty about the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100